ClinVar Miner

Submissions for variant NM_181798.1(KCNQ1):c.1207C>T (p.Gln403Ter) (rs397508097)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000619891 SCV000738152 pathogenic Cardiovascular phenotype 2017-08-23 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
Fulgent Genetics,Fulgent Genetics RCV000515204 SCV000611204 pathogenic Atrial fibrillation, familial, 3; Beckwith-Wiedemann syndrome; Long QT syndrome 1; Jervell and Lange-Nielsen syndrome 1; Short QT syndrome 2 2017-05-18 criteria provided, single submitter clinical testing
GeneDx RCV000182204 SCV000234507 pathogenic not provided 2018-09-12 criteria provided, single submitter clinical testing The Q530X pathogenic variant in the KCNQ1 gene has previously been reported in heterozygous individuals with autosomal dominant LQTS (Splawski et al., 2000; Zareba et al., 2003; Berge et al., 2008; Kapplinger at al., 2009; Christiansen et al., 2014) and in homozygous or compound heterozygous individuals with autosomal recessive JLNS (Tranebjaerg et al., 1999; Huang et al., 2001; Ning et al., 2003; Giudicessi et al., 2013; Früh et al., 2016). This variant has been identified as a founder mutation in the Swedish population (Stattin et al., 2012; Winbo et al., 2012). Q530X has also been identified in multiple unrelated individuals diagnosed with LQTS referred for genetic testing at GeneDx. In addition, the Q530X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The Q530X variant is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Functional studies demonstrate that Q530X results in a loss of function of the potassium channel (Huang et al., 2001; Westenskow et al., 2004; Mousavi et al., 2015). Finally, multiple other downstream nonsense variants in the KCNQ1 gene have been reported in Human Gene Mutation Database in association with LQTS (Stenson et al., 2014). In summary, Q530X in theKCNQ1 gene is interpreted as a pathogenic variant.
Gharavi Laboratory,Columbia University RCV000182204 SCV000809458 pathogenic not provided 2018-09-16 no assertion criteria provided research
Invitae RCV000046003 SCV000074016 pathogenic Long QT syndrome 2018-08-28 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal at codon 530 (p.Gln530*) of the KCNQ1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ1 are known to be pathogenic. This particular variant has been reported in the heterozygous state in multiple individuals with long QT syndrome (PMID: 14678125, 19716085, 24606995) and in the homozygous or compound heterozygous state in several individuals with Jervell and Lange-Nielsen syndrome (PMID: 11530100, 14510661, 23392653, 22629021). This variant has been confirmed in experimental assays to be non-functional (PMID: 15051636, 24912595). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.